Neurologist Faces His Alzheimer Diagnosi...

Epidemiologist Brian Lee, PhD, discusses his study on acetaminophen use during pregnancy and children’s risk of autism and other neurodevelopmental disorders in this interview with JAMA Deputy Editor Linda Brubaker, MD. Related Content: Acetaminophen Use in Pregnancy—Study Author ... Show More

Ultraprocessed Foods and Cardiometabolic Health—New Report on a “Growing Public Health Challenge”; New Analysis of Women’s Health Initiative Data Aims to “Clear the Air” Over Menopausal Hormone Therapy Related Content: New Analysis of Women’s Health Initiative Data Aims to “Clear ... Show More

Updates on GLP-1 drugs in heart failure, β-blockers after myocardial infarction, the shingles vaccine, and more: Felix Mahfoud, MD, chair of the Department of Cardiology at University Hospital Basel, shares clinical research highlights from the recent European Society of Cardiolo ... Show More

There are 6 million Americans living with Alzheimer's Disease. This program explains the latest understanding of the anatomy and functions of the brain and how it relates to neurological diseases. Dr. Gil Rabinovici is at the forefront of novel diagnostic testing to detect Alzhei ... Show More

Following National Alzheimer’s Disease Awareness Month, the CDC shares what physicians and patients need to know about the disease. Lisa McGuire, PhD, lead epidemiologist at the CDC, discusses the importance of catching Alzheimer’s early, its risk factors and barriers to make Alz ... Show More

Amanda Grant Smith is a geriatric psychiatrist with decades of experience treating patients with dementia and Alzheimer's disease. In this episode, Amanda shares how she developed a passion for geriatric psychiatry as a means to support dementia patients. She explains how to reco ... Show More

Alzheimer’s disease is a devastating neurodegenerative condition that affects the entire family. As psychiatrists and psychologists, we often support these patients and their families throughout this entire disease process. With the recent and controversial FDA approval of aducan ... Show More

This episode is brought to you by InsideTracker, Athletic Greens, and Paleovalley. Until recently, the most popular approach to treating Alzheimer’s has been to focus on managing the symptoms in the brain. Now brain experts and neurologists know that a better, more effective appr ... Show More

Dr. Mahinda Yogarajah discusses the importance of diagnosing and not misdiagnosing functional neurologic disorders. Show references: https://n.neurology.org/content/early/2023/06/20/WNL.0000000000207388 This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more inform ... Show More

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ... Show More

Links: Go to episode page (with episode resources) Subscribe to PREMIUM Get the Sigma email newsletter See Sigma's recommended resources About This Episode: Alzheimer’s disease has a profound impact on individuals, families, and societies worldwide. As a progressive neurodegenera ... Show More

Alzheimer's doesn't have to be your brain's destiny, says neuroscientist and author of "Still Alice," Lisa Genova. She shares the latest science investigating the disease -- and some promising research on what each of us can do to build an Alzheimer's-resistant brain. Hosted on A ... Show More

Dr. Gordon Smith talks with Laynie Dratch about integrating genetic testing into patient care for persons with Amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) spectrum disorders. Read the related article in Neurology: Clinical Practice.  Disclosures can ... Show More